Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that members of the executive team are scheduled to participate in a fireside chat at the TD Cowen 45th Annual Health Care Conference on Tuesday, March 4 at 8:50 a.m. PT / 11:50 a.m. ET in Boston, Massachusetts.

A live webcast of the fireside chat will be made available under Events & Presentations in the Investors section of the Vir Biotechnology website and will be archived for 30 days.

About Vir Biotechnology

Vir Biotechnology, Inc. is a clinical-stage biopharmaceutical company focused on powering the immune system to transform lives by discovering and developing medicines for serious infectious diseases and cancer. Its clinical-stage portfolio includes infectious disease programs for chronic hepatitis delta and chronic hepatitis B infections and multiple dual-masked T-cell engagers across validated targets in solid tumor indications. Vir Biotechnology also has a preclinical portfolio of programs across a range of infectious diseases and oncologic malignancies. Vir Biotechnology routinely posts information that may be important to investors on its website.

Media Arran Attridge Senior Vice President, Corporate Communications aattridge@vir.bio

Investors Richard Lepke Senior Director, Investor Relations rlepke@vir.bio

Vir Biotechnology (NASDAQ:VIR)
과거 데이터 주식 차트
부터 2월(2) 2025 으로 3월(3) 2025 Vir Biotechnology 차트를 더 보려면 여기를 클릭.
Vir Biotechnology (NASDAQ:VIR)
과거 데이터 주식 차트
부터 3월(3) 2024 으로 3월(3) 2025 Vir Biotechnology 차트를 더 보려면 여기를 클릭.